New York, NY (July 8, 2010) -- The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting exceptional early career researchers and innovative cancer research, named 18 new Damon Runyon Fellows at its spring Fellowship Award Committee review. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($156,000 each) to work on innovative projects.
May 2010 Damon Runyon Fellows:
Niels Bradshaw, PhD, with his sponsor Richard M. Losick, PhD, at Harvard University, Cambridge, Massachusetts, is studying the regulation of an enzyme called protein phosphatase that acts in specific cells to promote cellular differentiation. Protein phosphatases are required for many processes, including cell growth, division, differentiation and stress adaptation. He hopes that understanding phosphatase regulation will clarify the role of these enzymes in cancer and potentially aid in the development of anti-cancer therapies that target phosphatases.
Elizabeth M. Duncan, PhD [HHMI Fellow] with her sponsor Alejandro Snchez Alvarado, PhD, at the University of Utah, Salt Lake City, Utah, is examining how DNA-sequence-independent (epigenetic) mechanisms regulate gene expression during regeneration in the planarian flatworm. Such mechanisms are involved in the establishment and maintenance of cellular memory; understanding the normal function of epigenetics will lead to a better understanding of how their misregulation leads to cancer.
Kimberly Evason, MD, PhD, with her sponsor Didier Y.R. Stainier, PhD, at the University of California, San Francisco, California, is studying liver development and liver tumor
|Contact: Yung S. Lie, PhD|
Damon Runyon Cancer Research Foundation